In this study, we found that metformin pretreatment significantly reduced the mRNA levels of cytokines stimulated by IL-1β and reduced inflammation at the protein level; these results are similar to previous findings in uveitis [37], other autoimmune diseases [38,40,42,43,44,45], and TAO [46]. Here, IL1B is linked to autoimmune disease.